Physician profile
Eric Ishibashi
NPI 1205953643
$2,368.41
in general payments reported to CMS, 2019-2025
16 companies · $563 in 2025
The $563 reported for 2025 was more than what 80% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $186 · 2020: $81.07 · 2021: $81.85 · 2022: $681 · 2023: $306 · 2024: $470 · 2025: $563.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,321 · Education: $17.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,321.09 |
| Education | $17.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $721.13 | 2022-2025 | |
| Oyster Point Pharma, INC. | $422.76 | 2022-2025 | Tyrvaya |
| Sun Pharmaceutical Industries INC. | $262.27 | 2019-2025 | Cequa |
| Allergan, INC. | $209.97 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $174.30 | 2020-2023 | |
| Alcon Vision LLC | $136.40 | 2022-2025 | Rocklatan |
| Bausch & Lomb Americas INC. | $121.55 | 2022-2025 | Miebo |
| Mallinckrodt Hospital Products INC. | $57.54 | 2023-2024 | Acthar |
| Tarsus Pharmaceuticals, INC. | $52.42 | 2025 | Xdemvy |
| Harrow Eye, LLC | $48.64 | 2025 | Vevye |
| Shire North American Group INC | $38.41 | 2019 | |
| Biotissue Holdings INC. | $35.56 | 2019-2022 | |
| Dompe US, INC. | $30.86 | 2024 | Oxervate |
| Aerie Pharmaceuticals, INC. | $24.83 | 2019 | |
| Glaukos Corporation | $17.36 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Surgical Vision, INC. | $14.41 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Ishibashi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.